Cytoprotective effect of amifostine in the treatment of childhood neoplastic diseases - a clinical study including the pharmacoeconomic analysis.

Journal Title: Pharmacological Reports - Year 2006, Vol 58, Issue 1

Abstract

Amifostine is an active aminothiol, which has unique properties as a radio-and chemoprotective agent. It has been reported to prevent myelosuppresion and reduce the toxic effects of intensive cancer treatment. In the study, 57 courses of chemotherapy in 18 children treated because of neoplastic disease were analyzed to assess the early side effects induced by cytotoxic anticancer therapy. In 18 of them amifostine was used as the cytoprotective agent. The estimation of adverse effects was made in accordance to WHO scale of toxicity, and the pharmacoeconomic analysis was based on the costs of intravenous antibiotics, G-CSF, GM-CSF, blood preparations, immunoglobulines and days of hospitalization. The amifostine use in supportive therapy of neoplastic diseases in children decreases the number of infections thanks to the diminishing of myelotoxic effect. This not only improves the comfort of the patient but also shortens the time of hospitalization. The amifostine therapy limits the costs of treatment, but high price of the drug itself, makes however, the chemotherapy with cytoprotection comparable in pharmacoeconomic analysis to the standard treatment.

Authors and Affiliations

Małgorzata Stolarska, Wojciech Młynarski, Beata Zalewska-Szewczyk, Jerzy Bodalski

Keywords

Related Articles

Hyperglycemia enhances the inhibitory effect of mitochondrial toxins and D,L-homocysteine on the brain production of kynurenic acid.

We have evaluated the effect of diabetes-mimicking conditions on the inhibition of kynurenic acid (KYNA) production exerted by mitochondrial toxins: 3-nitropropionic acid (3-NPA) and aminooxyacetic acid (AOAA), by endoge...

Involvement of NMDA receptors in the antidepressant-like action of adenosine.

Background and Method: In this work, the contribution of NMDA receptors to the antidepressant-like effect of adenosine in the forced swimming test (FST) was investigated. Results: The pretreatment of mice with NMDA or D-...

Therapeutic potential of plasma membrane-derived microparticles.

In the past, plasma membrane-derived microparticles were considered "cellular dust." According to the literature, circulating levels of microparticles are increased in several cardiovascular diseases associated with infl...

LC/MS/MS evaluation of cocaine and its metabolites in different brain areas, peripheral organs and plasma in cocaine self-administering rats.

We employed a cocaine intravenous self-administration model based on positive reinforcement of animals' instrumental reactions (i.e., lever pressing) rewarded by a dose of the drug. We also carried out simultaneous chara...

Stiripentol. A novel antiepileptic drug.

Epilepsy is one of the most widespread pathologies of human brain, affecting approximately 1% of world population. Despite the development of new methods of seizure control, chronic administration of antiepileptic drugs...

Download PDF file
  • EP ID EP144335
  • DOI -
  • Views 83
  • Downloads 0

How To Cite

Małgorzata Stolarska, Wojciech Młynarski, Beata Zalewska-Szewczyk, Jerzy Bodalski (2006). Cytoprotective effect of amifostine in the treatment of childhood neoplastic diseases - a clinical study including the pharmacoeconomic analysis.. Pharmacological Reports, 58(1), 30-34. https://europub.co.uk/articles/-A-144335